- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07635628
Motivational Interviewing on Diet, Lifestyle and Gestational Weight Gain of Pregnant Women (GLOW)
Effectiveness on Gestational Weight Gain of Pregnant Women of Motivational Interviewing on Diet and Lifestyle: a Randomized Controlled Trial
It is widely recognized that nutrition, metabolism and physical activity during pregnancy play a central role in several aspects of the health and well-being of pregnant women and their offspring. Pre-pregnancy Body Mass Index (BMI) and Gestational Weight Gain (GWG) are important predictors of maternal and neonatal health outcomes. In particular, excessive maternal pre-pregnancy BMI (BMI ≥ 25) and GWG outside the range recommended by the Institute of Medicine (IOM), may put mothers at risk of complications during pregnancy and delivery and can affect the short and long-term health of the offspring. They are also predicting factors of postpartum weight retention and long-term risk of offspring overweight or higher BMI. Similarly to obesity, also maternal pre-pregnancy underweight can cause negative health effects with short and long-term consequences for the mother and the foetus.
The most recent scientific evidence acknowledges the complex interplay between factors that influence the nutritional status and GWG of pregnant women, suggesting the need for multifaceted interventions that include counselling approaches, implemented during routine antenatal care for broad public health benefits. In particular, interventions based on health-related behavioural changes such as motivational interviewing (MI), used to address motivation, self-efficacy and self-regulation, have shown to have high chances of success. MI is a person-centred technique for communication that is effective for overcoming ambivalence and eliciting motivation for change.
The starting hypothesis is that inadequate GWG at the end of pregnancy may bear some relation with dietary habits and lifestyle before and during pregnancy and that MI might be effective in initiating and sustaining behavioural changes, including weight control. The study will compare a group of pregnant women, randomly assigned to receive, as part of the hospital-based prenatal care program, a behavioral intervention based on the MI methodology focused on dietary habits and lifestyle, with a group of women randomly assigned to the standard prenatal care program. It is expected that the dietary habits of women in the MI group will change as a result of the intervention, and that the resulting effective management of weight gain during pregnancy will contribute to improved maternal and neonatal outcomes.
Studie Overzicht
Toestand
Interventie / Behandeling
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Trieste, Italië, 34137
- Institute for Maternal and Child Health - IRCCS "Burlo Garofolo"
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Pregnant women >=18 years, accessing hospital for the first scheduled ultrasound scan at 11-13 weeks of gestation and who express the intention of giving birth in the recruiting hospital
Exclusion Criteria:
- gestational age at enrollment > 15 weeks
- preexisting type 1 diabetes
- multiple pregnancy
- insufficient knowledge of the Italian language.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Experimental Group (EG)
In addition to usual antenatal care (UC), the Experimental Group (EG) will receive four prenatal MI sessions between 11 and 15 weeks of gestation (T1), between 18 and 22 weeks (T2), between 24 and 28 weeks (T3), and between 30 and 34 weeks (T4).
|
The four MI sessions, centered on eating habits, physical activity and lifestyle behaviours, will be led by a multidisciplinary group of health professionals - dieticians/nutritionists/ expert in motor sciences/psychologist - trained by a psychologist with expertise in MI.
During the motivational sessions, personal barriers to behavioural change will be explored and positive verbal reinforcement will be given to increase self-confidence and self-efficacy.
Women will be asked to identify the lifestyle behaviours they need to change and to set small stepwise goals based on their own intention to achieve a healthier lifestyle.
Weight will be measured and GWG monitored at each of the four sessions.
|
|
Geen tussenkomst: Control Group (CG)
The Control Group (CG) will only receive the usual antenatal care (UC)
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Percentage of Women With Adequate Gestational Weight Gain According to Institute of Medicine Guidelines
Tijdsspanne: At delivery
|
Gestational weight gain will be calculated as maternal weight at delivery minus self-reported pre-pregnancy weight. Adequate gestational weight gain will be defined according to the Institute of Medicine guidelines, based on pre-pregnancy body mass index category. The outcome will be reported as the percentage of women with gestational weight gain within the recommended range: number of women with adequate gestational weight gain / total number of women assessed x100 |
At delivery
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Gestational age at delivery
Tijdsspanne: At delivery
|
Gestational age at delivery will be calculated in completed weeks of gestation, based on the first day of the last menstrual period and/or obstetric dating.
The outcome will be reported as a continuous variable.
|
At delivery
|
|
Mode of delivery
Tijdsspanne: At delivery
|
Mode of delivery will be categorized as spontaneous vaginal delivery, assisted vaginal delivery by vacuum or forceps, or cesarean delivery.
The outcome will be reported as the number and percentage of women in each category.
|
At delivery
|
|
Newborn birth weight
Tijdsspanne: within 30 minute after birth
|
Newborn birth weight will be measured in grams and abstracted from the delivery or neonatal medical record.
The outcome will be reported as a continuous variable
|
within 30 minute after birth
|
|
Newborn birth length
Tijdsspanne: within 30 minute after birth
|
Newborn birth length will be measured in centimeters and abstracted from the delivery or neonatal medical record.
The outcome will be reported as a continuous variable
|
within 30 minute after birth
|
|
Apgar Score at 1 Minute After Birth
Tijdsspanne: 1 minutes after birth
|
Neonatal well-being will be assessed using the Apgar score at 1 minute after birth.
The Apgar score ranges from 0 to 10, with higher scores indicating better neonatal condition.
The outcome will be reported as a score or, if pre-specified, as the number and percentage of newborns with Apgar score less than 7
|
1 minutes after birth
|
|
Apgar Score at 5 Minute After Birth
Tijdsspanne: 5 minutes after birth
|
Neonatal well-being will be assessed using the Apgar score at 5 minute after birth.
The Apgar score ranges from 0 to 10, with higher scores indicating better neonatal condition.
The outcome will be reported as a score or, if pre-specified, as the number and percentage of newborns with Apgar score less than 7
|
5 minutes after birth
|
|
Exclusive breastfeeding at Hospital Discharge
Tijdsspanne: At hospital discharge, expected within 2-5 days after delivery
|
Exclusive breastfeeding at hospital discharge will be defined as the newborn receiving only breast milk, with no formula or other liquids/foods, except medications or vitamin/mineral supplements if applicable.
The outcome will be reported as the percentage of mother-newborn dyads with exclusive breastfeeding at discharge.
|
At hospital discharge, expected within 2-5 days after delivery
|
|
Change in Dietary Behaviours from Baseline to 34 Weeks of Gestation
Tijdsspanne: Baseline and 34 weeks of gestation
|
Differences in consumption frequency by food group.
To evaluate consumption frequency a validated self-reported food frequency questionnaire will be used Dietary behaviours will be assessed using a validated self-reported food frequency questionnaire.
Dietary behaviours changes will be evaluated within and between groups and compared with the national dietary recommendations.
The outcome will be reported as the change from baseline to 34 weeks of gestation.
|
Baseline and 34 weeks of gestation
|
|
Gestational Weight Gain at 18-22 Weeks of Gestation
Tijdsspanne: 18 weeks 0 days to 22 weeks 6 days of gestation
|
Gestational weight gain at 18-22 weeks of gestation will be calculated as maternal weight measured between 18 weeks 0 days and 22 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
18 weeks 0 days to 22 weeks 6 days of gestation
|
|
Gestational Weight Gain at 24-28 Weeks of Gestation
Tijdsspanne: 24 weeks 0 days to 28 weeks 6 days of gestation.
|
Gestational weight gain at 24-28 weeks of gestation will be calculated as maternal weight measured between 24 weeks 0 days and 28 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
24 weeks 0 days to 28 weeks 6 days of gestation.
|
|
Gestational Weight Gain at 30-34 Weeks of Gestation
Tijdsspanne: 30 weeks 0 days to 34 weeks 6 days of gestation.
|
Gestational weight gain at 30-34 weeks of gestation will be calculated as maternal weight measured between 30 weeks 0 days and 34 weeks 6 days of gestation minus self-reported pre-pregnancy weight.
The outcome will be reported in kilograms
|
30 weeks 0 days to 34 weeks 6 days of gestation.
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Paola Pani, PhD, Institute for Maternal and Child Health IRCCS Burlo Garofolo
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Lichaamsgewicht
- Veranderingen in lichaamsgewicht
- Gewichtstoename
- Pathologische aandoeningen, tekenen en symptomen
- Tekenen en symptomen
- Gewichtstoename tijdens de zwangerschap
- Gezondheidsdiensten
- Gezondheidszorgfaciliteiten personeel en diensten
- Gedragsdisciplines en activiteiten
- Richtlijn counseling
- Counseling
- Geestelijke gezondheidszorg
- Motiverende interview
Andere studie-ID-nummers
- RC 07/24
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .